The cost of implementing a 2-1-1 call center-based cancer control navigator program

Lairson, David R.; Huo, Jinhai; Ricks, Katharine A Ball; Savas, Lara S.; Fernández, María E.

doi:10.1016/j.evalprogplan.2013.04.001

Cited by 11 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Eight of 10 articles found programs to be cost-effective. [128][129][130][131][132][133][134][135] Although the remaining studies did not assess returns on investment, they described costs associated with implementing a PN program, 136,[138][139][140][141] and they may be informative for institutions planning to create PN programs in the future.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The efficacy and cost‐effectiveness of patient navigation programs across the cancer continuum: A systematic review

Bernardo

Zhang

Hery

et al. 2019

Cancer

133

166

View full text Add to dashboard Cite

Published studies regarding patient navigation (PN) and cancer were reviewed to assess quality, determine gaps, and identify avenues for future research. The PubMed and EMBASE databases were searched for studies investigating the efficacy and cost‐effectiveness of PN across the cancer continuum. Each included article was scored independently by 2 separate reviewers with the Quality Assessment Tool for Quantitative Studies. The current review identified 113 published articles that assessed PN and cancer care, between August 1, 2010, and February 1, 2018, 14 of which reported on the cost‐effectiveness of PN programs. Most publications focused on the effectiveness of PN in screening (50%) and diagnosis (27%) along the continuum of cancer care. Many described the effectiveness of PN for breast cancer (52%) or colorectal cancer outcomes (51%). Most studies reported favorable outcomes for PN programs, including increased uptake of and adherence to cancer screenings, timely diagnostic resolution and follow‐up, higher completion rates for cancer therapy, and higher rates of attending medical appointments. Cost‐effectiveness studies showed that PN programs yielded financial benefits. Quality assessment showed that 75 of the 113 included articles (65%) had 2 or more weak components. In conclusion, this review indicates numerous gaps within the PN and cancer literature where improvement is needed. For example, more research is needed at other points along the continuum of cancer care outside of screening and diagnosis. In addition, future research into the effectiveness of PN for understudied cancers outside of breast and colorectal cancer is necessary along with an assessment of cost‐effectiveness and more rigorous reporting of study designs and results in published articles.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Ten studies assessed cost-effectiveness: 8 found that PN programs were cost-effective, 128-135 and 2 did not observe cost-effectiveness for the PN intervention. 136,137 Five articles assessed only the cost of implementing a PN program and did not assess the return on investment 136,[138][139][140][141] (Table 1).…”

Section: Cost and Cost-effectiveness Of Pnmentioning

confidence: 99%

The efficacy and cost‐effectiveness of patient navigation programs across the cancer continuum: A systematic review

Bernardo

Zhang

Hery

et al. 2019

Cancer

133

166

View full text Add to dashboard Cite

show abstract

“…Some programs have proved successful with positive outcomes identified - such as improved patient care, better access to screening tests, and better cancer follow-up rates and timeliness [ 11 , 21 – 24 ]. Regarding their economic impact, few economic evaluations of such programs have been conducted for patients having cancer, though not specifically receiving oral therapeutics - with nuanced results on their cost-effectiveness, depending on the perspective adopted for the evaluation [ 25 , 26 ]. Overall, few studies have provided evidence regarding the impact on quality of care.…”

Section: Introductionmentioning

confidence: 99%

Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial

Gervès-Pinquié

Daumas-Yatim

Lalloué

et al. 2017

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundThe emergence of oral delivery in cancer therapeutics is expected to result in an increased need for better coordination between all treatment stakeholders, mainly to ensure adequate treatment delivery to the patient. There is significant interest in the nurse navigation program’s potential to improve transitions of care by improving communication between treatment stakeholders and by providing personalized organizational assistance to patients. The use of health information technology is another strategy aimed at improving cancer care coordination that can be combined with the NN program to improve remote patient follow-up. However, the potential of these two strategies combined to improve oral treatment delivery is limited by a lack of rigorous evidence of actual impact.Methods/designWe are conducting a large scale randomized controlled trial designed to assess the impact of a navigation program denoted CAPRI that is based on two Nurse Navigators and a web portal ensuring coordination between community and hospital as well as between patients and navigators, versus routine delivery of oral anticancer therapy. The primary research aim is to assess the impact of the program on treatment delivery for patients with metastatic cancer, as measured by Relative Dose Intensity. The trial involves a number of other outcomes, including tumor response, survival, toxic side effects, patient quality of life and patient experience An economic evaluation adopting a societal perspective will be conducted, in order to estimate those health. care resources’ used. A parallel process evaluation will be conducted to describe implementation of the intervention.DiscussionIf the CAPRI program does improve treatment delivery, the evidence on its economic impact will offer important knowledge for health decision-makers, helping develop new follow-up services for patients receiving oral chemotherapy and/or targeted therapy. The process evaluation will determine the best conditions in which such a program might be implemented.Trial registration NCT 02828462. Registered 29 June 2016.

show abstract

“…Costs for the implementation stage were based on the time spent by a health counselor, an advanced practice psychiatric nurse specialist, and a telemedicine and telehealth system coordinator involved in setting up the mobile distance clinic appointments. All personnel costs were based on their hourly wages reflecting the hours spent on each mobile distance clinic appointment 23 – 25 . The time spent by the interventionists was recorded for each mobile distance clinic appointment using time logs (see details in Table 1).…”

Section: Methodsmentioning

confidence: 99%

Costs of Multidisciplinary Parenteral Nutrition Care Provided at a Distance via Mobile Tablets

Kim

Spaulding

Werkowitch

et al. 2014

J Parenter Enteral Nutr

View full text Add to dashboard Cite

Background Determining the costs of healthcare delivery is a key step for providing efficient nutrition-based care. This analysis tabulates the costs of delivering home parenteral nutrition (HPN) interventions and clinical assessments through encrypted mobile technologies to increase patients’ access to healthcare providers, reduce their travel expenses, and allow early detection of infection and other complications. Methods A traditional cost-accounting method was used to tabulate all expenses related to mobile distance HPN clinic appointments, including (1) personnel time of multidisciplinary healthcare professionals, (2) supply of HPN intervention materials, and (3) equipment, connection, and delivery expenses. Results A total of 20 mobile distance clinic appointments were conducted for an average of 56 minutes each with 45 patients who required HPN infusion care. The initial setup costs included mobile tablet devices, 4G data plans, and personnel's time as well as intervention materials. The initial costs were on average $916.64 per patient, while the follow-up clinic appointments required $361.63 a month, with these costs continuing to decline as the equipment was used by multiple patients more frequently over time. Patients reported high levels of satisfaction with cost savings in travel expenses and rated the quality of care comparable to traditional in-person examinations. Conclusion This study provides important aspects of the initial cost tabulation for visual assessment for HPN appointments. These findings will be used to generate a decision algorithm for scheduling mobile distance clinic appointments intermittent with in-person visits to determine how to lower costs of nutrition assessments. To maximize the cost benefits, clinical trials must continue to collect clinical outcomes.

show abstract

The cost of implementing a 2-1-1 call center-based cancer control navigator program

Cited by 11 publications

References 22 publications

The efficacy and cost‐effectiveness of patient navigation programs across the cancer continuum: A systematic review

The efficacy and cost‐effectiveness of patient navigation programs across the cancer continuum: A systematic review

Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial

Costs of Multidisciplinary Parenteral Nutrition Care Provided at a Distance via Mobile Tablets

Contact Info

Product

Resources

About